Heart Health, Lipids & Blood Pressure
Cardiovascular disease, apoB, LDL, Lp(a), statins, blood pressure and heart risk.
20 episodes
~4 min read2:19:15
407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more
Michael Davidson14 Sept 202666.9K views
~6 min read1:16:49
Blood pressure: how to measure, manage, and treat high blood pressure (AMA #48 rebroadcast)
7 Sept 202639.1K views
~5 min read2:27:11
402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
Jim Otvos3 Aug 202620.6K views
~4 min read2:24:02
334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more
Thomas Dayspring3 Feb 2025109.7K views
~4 min read2:04:18
255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia
John Kastelein22 May 202330.5K views
~5 min read2:24:55
247 ‒ Preventing cardiovascular disease: the latest in imaging, blood pressure & metabolic health
Ethan Weiss20 Mar 2023116.6K views
~5 min read1:54:09
240 ‒ The confusion around HDL and its link to cardiovascular disease | Dan Rader, M.D.
Dan Rader30 Jan 202396.3K views
~4 min read2:15:04
230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more
Erin Michos7 Nov 202226.0K views
~4 min read1:18:53
229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB
Allan Sniderman, Tom Dayspring31 Oct 202277.7K views
~4 min read2:24:36
210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
Benoît Arsenault13 Jun 2022127.1K views
~5 min read2:25:35
Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast
Allan Sniderman29 Nov 2021307.3K views
~4 min read2:09:16
#134 - James O’Keefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise
James O'Keefe26 Oct 202068.9K views
~5 min read2:00:04
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Tom Dayspring, M.D.21 Sept 202034.7K views
~4 min read1:04:19
#22 – Tom Dayspring Part III of V: reverse cholesterol transport, CETP inhibitors, & apolipoproteins
Thomas Dayspring1 Jan 20209.8K views
~4 min read1:14:35
#20 – Tom Dayspring, M.D., FACP, FNLA – Part I of V: an introduction to lipidology
Thomas Dayspring1 Jan 202015.7K views
~4 min read1:27:02
#21 – Tom Dayspring, M.D., FACP, FNLA – Part II of V: Lipid metrics and cholesterol regulation
Tom Dayspring1 Jan 202016.5K views
~5 min read3:10:33
#19 – Dave Feldman: stress testing the lipid energy model
Dave Feldman1 Jan 202015.2K views
~5 min read1:29:47
#24 – Tom Dayspring, M.D., FACP, FNLA – Part V of V: Lp(a), inflammation, oxLDL, remnants, and more
Tom Dayspring1 Jan 20208.3K views
~5 min read2:00:15
#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain
Tom Dayspring1 Jan 202031.7K views
~5 min read1:16:16
#07 – Deep Dive: Lp(a) — what every doctor, and the 10-20% of the population at risk, needs to know
Peter Attia (deep dive)22 Dec 201914.0K views